COVID-19 Vaccines
COVID-19 Vaccines: How close are we?
2 min read
By Apollo 24/7, Published on - 16 October 2020, Updated on - 18 October 2022
Share this article
3
6 likes
- Pre-clinical phase (vaccine is tested on animals)
- Phase 1 (tested on 10-50 people)
- Phase 2 (tested on 100s of people)
- Phase 3 (tested on 1000s of people)
- Approval and Launch
- 156 vaccine candidates are in pre-clinical evaluation
- 42 are in the clinical evaluation stage (Ph 1, 2, 3)
- 10 of these are in the final phase (Ph 3)
- 3 vaccines are in various clinical trials in India (Ph 1, 2, 3)
- 1 vaccine in India is in the last phase (Ph 3) of clinical trial
- UK: 1 vaccine
- US: 4 vaccines
- China: 4 vaccines
- Russia: 1 vaccine
- India: 1 vaccine
- University of Oxford/AstraZeneca (UK)
- Moderna/NIAID (US)
- BioNTech/Fosun Pharma/Pfizer (US/Germany)
- Sinovac and Sinopharm (China)
- Gamaleya (Russia)
- The Serum Institute of India is conducting the final phase (Ph 3) of the Oxford/AstraZeneca vaccine trial in India
- Bharath Biotech & Zydus Cadila are manufacturing indigenous vaccines in India, and both are in phase 2 of trials
- The US FDA (Food & Drug Administration) is expected to start reviewing data from the trials by Nov/Dec 2020
- Some of the frontrunners are expected to request for EUA (emergency use authorization) by the end of the year
- The FDA has said that it will approve a vaccine if it develops immune response in at least 50% of the participants
- After the Government and health regulators approve, the vaccines will start becoming available
- These aspects are being worked out by the Government currently
- It is likely that frontline health workers will be among the first to receive
- High-risk people (e.g., seniors and individuals with comorbid conditions) may also be given priority
- The Government has said that the first vaccines could start becoming available by early 2021
- The Government expects 400-500 million vaccine doses to be available in 2021
- Register yourself with the vaccine tracker for the latest updates on COVID-19 vaccines.
COVID-19 Vaccines
Leave Comment
Recommended for you
COVID-19 Vaccines
The Benefits of Getting a COVID-19 Vaccine
While the vast majority of our country is waiting eagerly in anticipation of getting a vaccine, there are a few who are either unwilling or unsure about getting vaccinated.
COVID-19 Vaccines
Which COVID-19 vaccines have applied for emergency authorization in India?
After receiving Emergency Use Approval (EUA) in the United Kingdom, Pfizer has now approached the Indian and the U.S government for the same.
COVID-19 Vaccines
Frequently Asked Questions on COVID-19 vaccines
India has recently granted the ‘emergency use authorisation’ of two vaccines - Covishield and Covaxin to fight the Coronavirus.
Subscribe
Sign up for our free Health Library Daily Newsletter
Get doctor-approved health tips, news, and more.
Visual Stories
COVID-19 Vaccine Roundup [22.03.2021]
Tap to continue exploring
Recommended for you
COVID-19 Vaccines
The Benefits of Getting a COVID-19 Vaccine
While the vast majority of our country is waiting eagerly in anticipation of getting a vaccine, there are a few who are either unwilling or unsure about getting vaccinated.
COVID-19 Vaccines
Which COVID-19 vaccines have applied for emergency authorization in India?
After receiving Emergency Use Approval (EUA) in the United Kingdom, Pfizer has now approached the Indian and the U.S government for the same.
COVID-19 Vaccines
Frequently Asked Questions on COVID-19 vaccines
India has recently granted the ‘emergency use authorisation’ of two vaccines - Covishield and Covaxin to fight the Coronavirus.